Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from DENTSPLY SIRONA ( (XRAY) ).
On February 11, 2025, Dentsply Sirona announced it is evaluating strategic alternatives for its Wellspect Healthcare business, a leading provider in bladder and bowel management care products. This decision is part of the company’s broader transformation strategy aimed at unlocking value for stakeholders and refocusing efforts on its core dental business. Wellspect has shown strong growth in recent years and holds a significant position in the $2 billion continence care market. The review process does not have a set timeline and may or may not result in a transaction.
More about DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, known for its innovative solutions in dental and oral health. The company, headquartered in Charlotte, North Carolina, develops, manufactures, and markets a wide range of dental care products and consumable medical devices under renowned brands. Its shares trade on Nasdaq under the symbol XRAY.
YTD Price Performance: -1.55%
Average Trading Volume: 2,679,458
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.73B
Learn more about XRAY stock on TipRanks’ Stock Analysis page.
